Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation

Sara M Garrido; Thomas R Chauncey

Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Bone marrow transplantation
Volume	21
State	Published - 1998

Disciplines

Medicine and Health Sciences

Cite this

@article{574dc1ec845a4601a0603c81f705493e,

title = "Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation",

author = "Garrido, {Sara M} and Chauncey, {Thomas R}",

note = "Neuroleptic malignant syndrome (NMS) is a rare disorder characterized by hyperthermia, elevated creatine phosphokinase, extrapyramidal effects, autonomic instability, altered level of consciousness and leukocytosis associated with neuroleptic and other psychotropic medications. There are no cases of NMS reported following stem cell transplantation.",

year = "1998",

language = "American English",

volume = "21",

journal = "Bone marrow transplantation",

}

TY - JOUR

T1 - Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation

AU - Garrido, Sara M

AU - Chauncey, Thomas R

N1 - Neuroleptic malignant syndrome (NMS) is a rare disorder characterized by hyperthermia, elevated creatine phosphokinase, extrapyramidal effects, autonomic instability, altered level of consciousness and leukocytosis associated with neuroleptic and other psychotropic medications. There are no cases of NMS reported following stem cell transplantation.

PY - 1998

Y1 - 1998

UR - https://www.ncbi.nlm.nih.gov/pubmed/9509981

M3 - Article

VL - 21

JO - Bone marrow transplantation

JF - Bone marrow transplantation

ER -

Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation

Disciplines

Other files and links

Cite this